Cobalamin (Cbl), or vitamin Bit, is required for activity of the mitochondr
ial enzyme, methyl-malonyl-CoA mutase, and the cytoplasmic enzyme, methioni
ne synthase. A number of inborn errors affecting ability to absorb dietary
cobalamin or to convert exogenous cobalamin to its active coenzyme derivati
ves have been recognized. Intrinsic factor deficiency and Imerslund-Grasbec
k syndrome result in inability to absorb dietary cobalamin from the gut. Tr
anscobalamin II deficiency results in dcreased levels of the blood cobalami
n binding protein that facilitates cellular cobalamin uptake. The inborn er
rors of cobalamin metabolism, the CblA-CblH disorders, result in inability
to synthesize one or both of the cobalamin coenzyme derivatives, adenosylco
balamin and methylcobalamin, resulting in methylmalonic aciduria or hyperho
mocystinemia and hypomethioninemia, or both.